secwatch / observer
8-K filed February 20, 2025, 6:59 PM ET ticker IFF CIK 0000051253
leadership confidence high sentiment neutral materiality 0.40

IFF: Health & Biosciences president Simon Herriott leaves; Leticia Goncalves Lourenço appointed

INTERNATIONAL FLAVORS & FRAGRANCES INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leticia Goncalves Lourenço

President, Health & Biosciences
IFF · INTERNATIONAL FLAVORS & FRAGRANCES INC
Effective
2025-03-01
Filed
February 20, 2025, 6:59 PM ET
Effective March 1, 2025, Leticia Goncalves Lourenço will join IFF as President of the Company’s Health & Biosciences division.
Departed

Simon Herriott

President, Health & Biosciences
IFF · INTERNATIONAL FLAVORS & FRAGRANCES INC
Effective
2025-03-31
Successor
Leticia Goncalves Lourenço
Filed
February 20, 2025, 6:59 PM ET
Simon Herriott, who is currently President, Health & Biosciences, will be leaving IFF on March 31, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Leticia Goncalves Lourenço was appointed as President, Health & Biosciences at INTERNATIONAL FLAVORS & FRAGRANCES INC.

Action
will join
Role
President, Health & Biosciences
Exact text from the filing
Effective March 1, 2025, Leticia Goncalves Lourenço will join IFF as President of the Company’s Health & Biosciences division.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Simon Herriott departed as President, Health & Biosciences at INTERNATIONAL FLAVORS & FRAGRANCES INC.

Action
leaving
Role
President, Health & Biosciences
Exact text from the filing
Simon Herriott, who is currently President, Health & Biosciences, will be leaving IFF on March 31, 2025.
View on SEC.gov

INTERNATIONAL FLAVORS & FRAGRANCES INC filing history →

Source: SEC EDGAR
accession 0001193125-25-030788
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.